Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 38, 2009 - Issue 5
Submit an article Journal homepage
704
Views
63
CrossRef citations to date
0
Altmetric
Articles

Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors

SA Exarchou Rheumatology Clinic, Department of Internal Medicine
,
PV Voulgari Rheumatology Clinic, Department of Internal Medicine
,
TE Markatseli Rheumatology Clinic, Department of Internal Medicine
,
A Zioga Department of Pathology, Medical School, University of Ioannina, Ioannina, Greece
&
AA Drosos Rheumatology Clinic, Department of Internal MedicineCorrespondence[email protected]
Pages 328-331 | Published online: 08 Oct 2009

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Poonkiat Suchonwanit, Chaninan Kositkuljorn & Cherrin Pomsoong. (2021) Alopecia Areata: An Autoimmune Disease of Multiple Players. ImmunoTargets and Therapy 10, pages 299-312.
Read now
Eleftherios Pelechas, Paraskevi V Voulgari & Alexandros A. Drosos. (2021) Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert Opinion on Drug Discovery 16:3, pages 227-234.
Read now
Marta Pérez-De-Lis, Soledad Retamozo, Alejandra Flores-Chávez, Belchin Kostov, Roberto Perez-Alvarez, Pilar Brito-Zerón & Manuel Ramos-Casals. (2017) Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Expert Opinion on Drug Safety 16:11, pages 1255-1271.
Read now
Paraskevi V Voulgari & Alexandros A Drosos. (2014) Adalimumab in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 14:4, pages 549-561.
Read now
Paraskevi V Voulgari, Evripidis Kaltsonoudis, Charalampos Papagoras & Alexandros A Drosos. (2012) Adalimumab in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 12:12, pages 1679-1686.
Read now
Giampiero Girolomoni, Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Piergiacomo Calzavara-Pinton, Sergio Chimenti, Andrea Peserico, Antonio Puglisi Guerra & Gino Antonio Vena. (2012) Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacology and Immunotoxicology 34:4, pages 548-560.
Read now

Articles from other publishers (57)

Aliki I. Venetsanopoulou, Konstantina Mavridou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2023) Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations. Seminars in Arthritis and Rheumatism 63, pages 152272.
Crossref
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2023) TNFα inhibitor biosimilar associated with polychondritis. A case-based review. Rheumatology International 43:9, pages 1751-1754.
Crossref
Jessica Mounessa, Joseph V. Caravaglio, Renee Domozych, Stephanie Chapman, Robert P. Dellavalle, Cory A. Dunnick & David Norris. (2023) Commonly prescribed medications associated with alopecia. Journal of the American Academy of Dermatology 88:6, pages 1326-1337.e2.
Crossref
Priyanka Karagaiah, Robert A. Schwartz, Torello Lotti, Uwe Wollina, Stephan Grabbe & Mohamad Goldust. (2022) Biologic and targeted therapeutics in vitiligo. Journal of Cosmetic Dermatology 22:1, pages 64-73.
Crossref
Anna Ballová, Zlata Kmečová, Juraj Péč & Karolína Vorčáková. (2022) Recalcitrant granuloma annulare induced by two different biologic agents resolved after Janus kinase inhibitor treatment. Dermatologic Therapy 35:8.
Crossref
E. Pelechas, P. V. Voulgari & A. A. Drosos. (2022) TNFα inhibitor biosimilars associated with alopecia areata. Case-based review. Rheumatology International 42:6, pages 1113-1117.
Crossref
Anastasia Skalkou, Eleftherios Pelechas, Paraskevi V. Voulgari & Alexandros A. Drosos. (2022) TNF-induced Lupus. A Case-Based Review. Current Rheumatology Reviews 18:1, pages 72-82.
Crossref
Nada Jaouad, Kawther Ben Abdelghani, Meriem Sellami, Fadoua Khadiri, Bouchra Amine, Imane Elbinoune, Alia Fazaa, Ahmed Laatar & Rachid Bahiri. (2021) Vitiligo and anti-tumor necrosis factors: Cases report. Therapies 76:5, pages 504-507.
Crossref
Eleftherios Pelechas, Alexandra Papoudou-Bai, Paraskevi V. Voulgari & Alexandros A. Drosos. (2021) Cutaneous Autoimmune Phenomena of the Anti-TNFa Biosimilars. Casebased Review. Current Rheumatology Reviews 17:2, pages 267-270.
Crossref
Annunziata Raimondo, Giulia Guglielmi, Carlo Marino, Luigi Ligrone & Serena Lembo. (2021) Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab. JAAD Case Reports 11, pages 51-53.
Crossref
Alice Wang, Nur-Taz Rahman, Meaghan K. McGeary, Michael Murphy, Austin McHenry, Danielle Peterson, Marcus Bosenberg, Richard A. Flavell, Brett King & William Damsky. (2021) Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib. Journal of Allergy and Clinical Immunology 147:5, pages 1795-1809.
Crossref
Samily Oliveira, Antonio Helder Costa Vasconcelos, Emmanuel Pereira Benevides Magalhães, Fernanda Judith Vieira Corrêa & Carlos Ewerton Maia Rodrigues. (2020) Clinical, Histopathological and Outcome Analysis of Five Patients With Lichenoid Eruption Following Anti-Tumor Necrosis Factor-Alpha Therapy for Ankylosing Spondylitis: Report of One Case and Review of the Literature. Cureus.
Crossref
Andrés Tirado-Sánchez & Alexandro Bonifaz. (2020) Simultaneous bullous pemphigoid and vitiligo associated with adalimumab therapy in a patient with psoriasis vulgaris. Indian Dermatology Online Journal 11:2, pages 229.
Crossref
Christopher R Holroyd, Rakhi Seth, Marwan Bukhari, Anshuman Malaviya, Claire Holmes, Elizabeth Curtis, Christopher Chan, Mohammed A Yusuf, Anna Litwic, Susan Smolen, Joanne Topliffe, Sarah Bennett, Jennifer Humphreys, Muriel Green & Jo Ledingham. (2019) The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology 58:2, pages e3-e42.
Crossref
Eleftherios Pelechas, Alexandra Papoudou-Bai, Paraskevi V. Voulgari & Alexandros A. Drosos. (2018) Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review. Rheumatology International 39:2, pages 353-357.
Crossref
Christos G Papadopoulos, Ilias K Gartzonikas, Tatiani K Pappa, Theodora E Markatseli, Michael P Migkos, Paraskevi V Voulgari & Alexandros A Drosos. (2019) Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry. Rheumatology Advances in Practice 3:1.
Crossref
Eleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari & Alexandros A. DrososEleftherios Pelechas, Evripidis Kaltsonoudis, Paraskevi V. Voulgari & Alexandros A. Drosos. 2019. Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases. Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases 343 367 .
Jung Min Bae, Miri Kim, Han Hee Lee, Ki-Jo Kim, Hyoseung Shin, Hyun Jeong Ju, Gyong Moon Kim, Chul Jong Park & Hyun Jeong Park. (2018) Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study. Journal of Investigative Dermatology 138:4, pages 768-774.
Crossref
Anuradha Bishnoi & Davinder Parsad. 2018. Vitiligo. Vitiligo 123 131 .
L. Méry-Bossard, K. Bagny, G. Chaby, A. Khemis, F. Maccari, H. Marotte, J.L. Perrot, Z. Reguiai, M.L. Sigal, M. Avenel-Audran, T. Boyé, A. Grasland, J. Gillard, D. Jullien & E. Toussirot. (2017) New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases. Journal of the European Academy of Dermatology and Venereology 31:1, pages 181-186.
Crossref
Chantal Bolduc, Leonard C. Sperling & Jerry Shapiro. (2016) Primary cicatricial alopecia. Journal of the American Academy of Dermatology 75:6, pages 1081-1099.
Crossref
Johnny Bourke. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 21 .
Giulio CavalliMasahiro HayashiYing JinDaniel YorgovStephanie A. SantoricoCherie HolcombMelinda RastrouHenry ErlichIsak W. TengesdalLorenzo DagnaC. Preston NeffBrent E. PalmerRichard A. SpritzCharles A. Dinarello. (2016) MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proceedings of the National Academy of Sciences 113:5, pages 1363-1368.
Crossref
K.C. WebbR. TungL.S. WinterfieldA.B. GottliebJ.M. EbyS.W. HenningI.C. Le Poole. (2015) Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. British Journal of Dermatology 173:3, pages 641-650.
Crossref
Carolina Forte Amarante, Livia Mendes Sabia Acedo, Fátima Maria de Oliveira Rabay, Benedito do Espírito Santo Campos, Márcia Lanzoni de Alvarenga Lira & Samuel Henrique Mandelbaum. (2015) Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab. Anais Brasileiros de Dermatologia 90:3 suppl 1, pages 121-124.
Crossref
Benjamin S Daniel & Richard Wittal. (2015) Vitiligo treatment update. Australasian Journal of Dermatology 56:2, pages 85-92.
Crossref
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Daniel Feldman Pollak, Geraldo da Rocha Castelar Pinheiro, Ieda Maria Magalhães Laurindo, Ivânio Alves Pereira, Jozélio Freire de Carvalho, Manoel Barros Bertolo, Marcelo de Medeiros Pinheiro, Max Victor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Júnior, Percival Degrava Sampaio-Barros, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima & Luis Eduardo Coelho Andrade. (2015) Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides. Revista Brasileira de Reumatologia (English Edition) 55:3, pages 281-309.
Crossref
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Daniel Feldman Pollak, Geraldo da Rocha Castelar Pinheiro, Ieda Maria Magalhães Laurindo, Ivânio Alves Pereira, Jozélio Freire de Carvalho, Manoel Barros Bertolo, Marcelo de Medeiros Pinheiro, Max Victor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada‐Júnior, Percival Degrava Sampaio‐Barros, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima & Luis Eduardo Coelho Andrade. (2015) Segurança do uso de terapias biológicas para o tratamento de artrite reumatoide e espondiloartrites. Revista Brasileira de Reumatologia 55:3, pages 281-309.
Crossref
Joon Min JungYe Jin LeeChong Hyun WonSung Eun ChangMi Woo LeeJee Ho ChoiKee Chan Moon. (2015) Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?. Annals of Dermatology 27:5, pages 620.
Crossref
H Lee, D S Kim & K Y Chung. (2014) Adalimumab-induced lupus panniculitis. Lupus 23:13, pages 1443-1444.
Crossref
Amir Kalafi & Farideh Jowkar. (2014) Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. ISRN Dermatology 2014, pages 1-6.
Crossref
Murielle Michel, Patrick Henri, Fabien B. Vincent, Nathalie Leon & Christian Marcelli. (2014) Glomérulonéphrite à dépôts mésangiaux d’immunoglobulines (Ig)A chez un patient présentant une polyarthrite rhumatoïde traitée par abatacept. Revue du Rhumatisme 81:1, pages 89-92.
Crossref
Murielle Michel, Patrick Henri, Fabien B. Vincent, Nathalie Leon & Christian Marcelli. (2013) Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept. Joint Bone Spine 80:6, pages 660-663.
Crossref
É. Toussirot, D. Salard, M.-P. Algros & F. Aubin. (2013) Développement d’un vitiligo au cours du traitement d’une spondylarthrite ankylosante par adalimumab. Annales de Dermatologie et de Vénéréologie 140:12, pages 801-802.
Crossref
Mª Victoria Hernández, Raimon Sanmartí, Juan D. Cañete, Miguel A. Descalzo, Mercè Alsina, Loreto Carmona & Juan J. Gomez-Reino. (2013) Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases. Arthritis Care & Research 65:12, pages 2024-2031.
Crossref
G. W. Moran, A. W. K. Lim, J. L. Bailey, M.-F. Dubeau, Y. Leung, S. M. Devlin, K. Novak, G. G. Kaplan, M. Iacucci, C. Seow, L. Martin, R. Panaccione & S. Ghosh. (2013) Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 38:9, pages 1002-1024.
Crossref
Carlos R. Camara-Lemarroy & Julio C. Salas-Alanis. (2013) The Role of Tumor Necrosis Factor-α in the Pathogenesis of Vitiligo. American Journal of Clinical Dermatology 14:5, pages 343-350.
Crossref
Edoardo Zattra, Roxana Stan, Irene Russo, Alessandro Lo Nigro, Andrea Peserico & Mauro Alaibac. (2013) TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?. Immunotherapy 5:8, pages 791-794.
Crossref
Thivi Maruthappu, Maria Leandro & Susie D. Morris. (2013) Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab. Dermatologic Therapy 26:4, pages 370-372.
Crossref
P. Weisenseel & K. Reich. (2013) Paradoxe Hautreaktionen unter Therapie mit TNF-α-AntagonistenParadoxical skin reactions under therapy with TNF-alpha antagonists. Zeitschrift für Rheumatologie 72:5, pages 423-428.
Crossref
Hajnalka Jókai, József Szakonyi, Orsolya Kontár, Gábor Barna, Dóra Inotai, Sarolta Kárpáti & Péter Holló. (2013) Cutaneous lymphocyte‐associated antigen as a novel predictive marker of TNF ‐alpha inhibitor biological therapy in psoriasis . Experimental Dermatology 22:3, pages 221-223.
Crossref
Daniel Wendling, Caroline Biver-Dalle, Claire Vidon, Clément Prati & François Aubin. (2013) Lichen planus under anti TNF therapy for ankylosing spondylitis. Joint Bone Spine 80:2, pages 227-228.
Crossref
Maria Victoria Hernández, Melina Meineri & Raimon Sanmartí. (2013) Skin Lesions and Treatment With Tumor Necrosis Factor Alpha Antagonists. Reumatología Clínica (English Edition) 9:1, pages 53-61.
Crossref
Maria Victoria Hernández, Melina Meineri & Raimon Sanmartí. (2013) Lesiones cutáneas y terapia biológica con antagonistas del factor de necrosis tumoral. Reumatología Clínica 9:1, pages 53-61.
Crossref
Igor V. Korobko. (2012) Review of current clinical studies of vitiligo treatments. Dermatologic Therapy 25, pages S17-S27.
Crossref
Isabelle Cleynen & Séverine Vermeire. (2012) Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nature Reviews Gastroenterology & Hepatology 9:9, pages 496-503.
Crossref
Archana V. Patel, David M. Jones, Jerome C. Hill & Richard P. MacDermott. (2012) Development of metastatic Crohnʼs disease of the skin while on Anti-TNF biologics. Inflammatory Bowel Diseases 18:6, pages 1188-1190.
Crossref
Elena B. Hawryluk, Katy R. Linskey, Lyn M. Duncan & Rosalynn M. Nazarian. (2012) Broad range of adverse cutaneous eruptions in patients on TNF‐alpha antagonists. Journal of Cutaneous Pathology 39:5, pages 481-492.
Crossref
A. Tammaro, S. Persechino, C. Abruzzese, A. Narcisi, G. Cortesi, F.R. Parisella & B. Laganà. (2012) Psoriasiform Dermatitis in a Non-Psoriatic Patient Treated with Adalimumab. International Journal of Immunopathology and Pharmacology 25:2, pages 499-501.
Crossref
Ran SongSo-Mi KimSang-Hoon LeeYeon-Ah LeeSeung-Jae HongHee-Ryung ChoGou-Young KimHyung-In Yang. (2012) A Case of Development of Vitiligo Followed by TNF-α Antagonist Treatment for Rheumatoid Arthritis. Journal of Rheumatic Diseases 19:4, pages 216.
Crossref
Victoria L. Williams & Philip R. Cohen. (2011) TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. International Journal of Dermatology 50:5, pages 619-625.
Crossref
E. Le Bidre, G. Chaby, L. Martin, M. Perrussel, B. Sassolas, M.-L. Sigal, C. Kaassis, E. Lespessailles, A. Nseir & E. Estève. (2011) Pelade au cours d’un traitement par anti-TNF alpha : neuf cas. Annales de Dermatologie et de Vénéréologie 138:4, pages 285-293.
Crossref
Pamela VEZZOLI, Silvia Alberti VIOLETTI, Stefano M. SERINI, Simona MURATORI, Emilio BERTI & Carlo CROSTI. (2010) Cutaneous lupus erythematosus induced by adalimumab. The Journal of Dermatology 38:3, pages 283-284.
Crossref
J.Q. Del Rosso & G.K. Kim. (2011) Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Yearbook of Dermatology and Dermatologic Surgery 2011, pages 217-218.
Crossref
D. Spoerl & Andreas J. Bircher. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 769 814 .
Charalampos Papagoras, Paraskevi V. Voulgari & Alexandros A. Drosos. (2010) Strategies after the failure of the first anti-tumor necrosis factor α agent in rheumatoid arthritis. Autoimmunity Reviews 9:8, pages 574-582.
Crossref
Cynthia H. Seow, Shanika de Silva, Gilaad G. Kaplan, Shane M. Devlin, Subrata Ghosh & Remo Panaccione. (2009) Managing the risks of IBD therapy. Current Gastroenterology Reports 11:6, pages 509-517.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.